To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us." -Dr. John Farley

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.

The findings, published in the Feb. 14 edition of The Lancet Oncology, show that selumetinib targets a mutation in the MAPK pathway for patients with low-grade serous carcinoma, allowing for treatment on previously chemoresistant tumors.

"This is a potentially important breakthrough for the Gynecologic Oncology Group," said John Farley, MD, a gynecologic oncologist in the Division of Gynecologic Oncology and the Department of Obstetrics and Gynecology at the Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, a Dignity Health Member.

This study was initially developed in 2007, with 52 patients enrolled for the Phase II clinical trial between December 2007 and November 2009. Patients were given 50 milligrams of selumetinib orally twice daily. Of those participants, eight had a measurable decrease in tumor size, seven had partial responses and 34 patients saw their tumors stabilize. The findings suggest that inhibitors of the MAPK pathway warrant further investigation in patients with low-grade ovarian cancer.

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us," Dr. Farley said. He added that Phase III of this trial is scheduled to begin in the next few weeks, with that trial to be the "definitive test" before the treatment becomes available to the general population.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

'Dream Come True for the USA': The Security Benefits of President Trump's Amazing Greenland Deal (Video)

Hollywood Refuses to Honor Chuck Norris at the Emmys

White House Chief of Staff Susie Wiles Says She is Cancer-Free

'Man of God': Juror Breaks Silence After Standing Alone in Lindsay Clancy Trial

Trump's EPA Takes Transformative Approach to Ending Plague of Plastic Waste

Who Pays for AI Data Center Costs? US House Says Big Tech, Not Consumers

AI: To Regulate or Not to Regulate, Here's What Is Really Behind the Arguments

Whistleblower Describes Kids Crying as the Becerra Machine (Under Biden) Trafficked Them to Strangers (Video)

President Trump Cites Major Decision Upcoming amid Evidence of Iran Nuclear Rebuild

House Passes Major Bills to Codify Trump Administration's $250 Billion Fraud Crackdown

Constitution Day 2026: The Hopes and the Challenges

Tiny English Village Stares Down Migrant Horde, Votes to Leave UK in 'Declaration of Independence'

Retail Sales Rebound in August, Exceed Economists' Expectations

Fed Rate Hike Means Tiny Increase on Credit Cards, Little Impact on Car Loans and Mortgages

'Out Of Control' Killings in Gov. Spanberger's Virginia Reach 'Insane' Point as Another Migrant Charged in Stabbing Spree

'Lying to Win': James Talarico's Lesbian Minister Just Outed Him (Video)

Feds Smash Multi-Million Dollar LA Homeless Fraud Scheme as Bigwig and 'Charity' Worker Dragged from Their Homes (Video)

We Prayed for Protection on 9/11. Days Later, an ISIS Plot Was Thwarted

MTV Star Leaves Gay Lifestyle After Encounter With Jesus (Video)

Trump Taps Franklin Graham's Daughter Cissie Graham Lynch for Leading Religious Freedom Role

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor